Biocartis prices EUR 100M IPO

Molecular diagnostics company Biocartis Group N.V. (Euronext:BCART) raised EUR 100 million ($107.8 million) through the sale of 8.7 million shares at EUR 11.50 in an IPO on Euronext Brussels. Underwriters were KBC Securities; Kempen; and Petercam. Biocartis said the offering was oversubscribed.

The IPO price valued Biocartis at EUR 450.2 million ($485.3 million). The company expects its shares to begin trading Monday, April 27. ...